Page last updated: 2024-08-25

chitosan and Candidiasis, Vulvovaginal

chitosan has been researched along with Candidiasis, Vulvovaginal in 13 studies

Research

Studies (13)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's5 (38.46)24.3611
2020's8 (61.54)2.80

Authors

AuthorsStudies
Choudhury, H; Gorain, B; Hsin, YK; Meng, LW; Pandey, M; Thangarajoo, T1
Shi, L; Wei, Y; Xu, S; Zhu, Q1
das Neves, J; de Camargo, ER; Martins, F; Morgado, DL; Sarmento, B1
Alves, SF; Amaral, AC; Costa, AF; da Silva, JT; Dantas de Sousa, PH; de Menezes, LB; Pellegrini, F1
Arumugam, G; Rajendran, R1
Amaral, AC; Araújo, DE; Cabral, MDS; Costa, AF; de Almeida Soares, CM; de Menezes, LB; de Oliveira, AA; do Carmo Silva, L; Pereira, M; Silva, BC1
Campana-Filho, SP; Colnago, LA; das Neves, J; Facchinatto, WM; Galante, J; Martins Dos Santos, D; Mesquita, L; Moraes, TB; Sarmento, B; Silva, DS1
Campos, LM; da Cruz, LF; da Silva, TP; de Freitas Araújo, MG; de Mello Botti, GCR; de Oliveira Lemos, AS; Denadai, ÂML; Fabri, RL; Júnior, JLR; Pinto, PF; Rocha, VN; Scio, E; Tavares, GD1
Borges de Menezes Leite, L; Correa Amaral, A; Evangelista Araujo, D; Fernandes Costa, A; Pereira, M; Santos Cabral, M; Teles Brito, I1
Auler, ME; de Camargo, LEA; Khalil, NM; Ludwig, DB; Mainardes, RM1
Amaral, AC; Bocca, AL; de Melo, MT; Morais, PC; Oliveira Souza, AC; Saavedra, PHV; Soares Felipe, MS; Tedesco, AC1
Alvarez, VA; Calvo, NL; Lamas, MC; Leonardi, D; Quiroga, AD; Svetaz, LA1
Abd Ellah, NH; Abdel-Aleem, JA; Abdo, MN; Abou-Ghadir, OF; Hetta, HF; Zahran, KM1

Trials

1 trial(s) available for chitosan and Candidiasis, Vulvovaginal

ArticleYear
Efficacy of ketoconazole gel-flakes in treatment of vaginal candidiasis: Formulation, in vitro and clinical evaluation.
    International journal of pharmaceutics, 2019, Aug-15, Volume: 567

    Topics: Adult; Antifungal Agents; Candida albicans; Candidiasis, Vulvovaginal; Chitosan; Drug Compounding; Drug Delivery Systems; Drug Liberation; Female; Gels; Humans; Ketoconazole; Middle Aged; Polysaccharides, Bacterial; Rheology; Young Adult

2019

Other Studies

12 other study(ies) available for chitosan and Candidiasis, Vulvovaginal

ArticleYear
Stimuli-Responsive in situ Spray Gel of Miconazole Nitrate for Vaginal Candidiasis.
    Journal of pharmaceutical sciences, 2023, Volume: 112, Issue:2

    Topics: Antifungal Agents; Candidiasis, Vulvovaginal; Chitosan; Delayed-Action Preparations; Female; Gels; Humans; Miconazole; Poloxamer

2023
Chitosan-coated miconazole as an effective anti-inflammatory agent for the treatment of postoperative infections in obstetrics and vaginal yeast infection control on in vitro evaluations.
    Microbial pathogenesis, 2023, Volume: 184

    Topics: Antifungal Agents; Candida albicans; Candidiasis, Vulvovaginal; Chitosan; Female; Humans; Miconazole; Microgels; Postoperative Complications

2023
Chitosan-based sponges containing clotrimazole for the topical management of vulvovaginal candidiasis.
    International journal of pharmaceutics, 2023, Nov-25, Volume: 647

    Topics: Administration, Topical; Antifungal Agents; Candida albicans; Candidiasis, Vulvovaginal; Chitosan; Clotrimazole; Female; Humans

2023
Fluconazole and propolis co-encapsulated in chitosan nanoparticles for the treatment of vulvovaginal candidiasis in a murine model.
    Medical mycology, 2023, Nov-06, Volume: 61, Issue:11

    Topics: Animals; Antifungal Agents; Candida albicans; Candidiasis, Vulvovaginal; Chitosan; Disease Models, Animal; Female; Fluconazole; Mice; Microbial Sensitivity Tests; Nanoparticles; Propolis; Rodent Diseases

2023
Callophycin A loaded chitosan and spicules based nanocomposites as an alternative strategy to overcome vaginal candidiasis.
    International journal of biological macromolecules, 2020, Oct-15, Volume: 161

    Topics: Animals; Candidiasis, Vulvovaginal; Carbolines; Chitosan; Disease Models, Animal; Female; Humans; Mice; Nanocomposites

2020
Investigation of thiosemicarbazide free or within chitosan nanoparticles in a murine model of vulvovaginal candidiasis.
    Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology], 2020, Volume: 51, Issue:4

    Topics: Animals; Antifungal Agents; Candida albicans; Candidiasis, Vulvovaginal; Chitosan; Drug Evaluation, Preclinical; Female; Mice; Mice, Inbred BALB C; Nanoparticles; Semicarbazides; Vagina

2020
Clotrimazole-loaded N-(2-hydroxy)-propyl-3-trimethylammonium, O-palmitoyl chitosan nanoparticles for topical treatment of vulvovaginal candidiasis.
    Acta biomaterialia, 2021, 04-15, Volume: 125

    Topics: Antifungal Agents; Candida; Candidiasis, Vulvovaginal; Chitosan; Clotrimazole; Female; Humans; Nanoparticles

2021
Development and in vivo evaluation of chitosan-gel containing Mitracarpus frigidus methanolic extract for vulvovaginal candidiasis treatment.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2020, Volume: 130

    Topics: Antifungal Agents; Candidiasis, Vulvovaginal; Chemical Phenomena; Chitosan; Dose-Response Relationship, Drug; Female; Humans; Plant Extracts; Rubiaceae; Vaginal Creams, Foams, and Jellies

2020
Development, characterization, and in vitro-in vivo evaluation of polymeric nanoparticles containing miconazole and farnesol for treatment of vulvovaginal candidiasis.
    Medical mycology, 2019, Jan-01, Volume: 57, Issue:1

    Topics: Animals; Antifungal Agents; BALB 3T3 Cells; Candida albicans; Candidiasis, Vulvovaginal; Capsules; Chitosan; Disease Models, Animal; Farnesol; Female; Mice; Mice, Inbred BALB C; Miconazole; Microbial Sensitivity Tests; Microbial Viability; Nanoparticles

2019
Antifungal Activity of Chitosan-Coated Poly(lactic-co-glycolic) Acid Nanoparticles Containing Amphotericin B.
    Mycopathologia, 2018, Volume: 183, Issue:4

    Topics: Amphotericin B; Animals; Antifungal Agents; Candida; Candidemia; Candidiasis, Vulvovaginal; Chitosan; Drug Carriers; Female; Humans; Lactic Acid; Microbial Sensitivity Tests; Nanoparticles; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Trichosporon; Urinary Tract Infections

2018
Miconazole loaded chitosan-based nanoparticles for local treatment of vulvovaginal candidiasis fungal infections.
    Colloids and surfaces. B, Biointerfaces, 2019, Feb-01, Volume: 174

    Topics: Administration, Intravaginal; Animals; Antifungal Agents; Candida albicans; Candidiasis, Vulvovaginal; Chitosan; Female; Humans; Mice; Mice, Inbred BALB C; Miconazole; Nanoparticles

2019
Chitosan-hydroxypropyl methylcellulose tioconazole films: A promising alternative dosage form for the treatment of vaginal candidiasis.
    International journal of pharmaceutics, 2019, Feb-10, Volume: 556

    Topics: Adhesiveness; Antifungal Agents; Candida albicans; Candidiasis, Vulvovaginal; Cell Line, Tumor; Chemistry, Pharmaceutical; Chitosan; Drug Carriers; Female; Humans; Hypromellose Derivatives; Imidazoles; Plasticizers; Polyethylene Glycols; X-Ray Diffraction

2019